CD8A and neoplasm: To examine these immune cells during the early stages of T cell activation, we analyzed tumor-infiltrating leukocytes (TILs) after a single vaccination in B16-OVA tumor-bearing mice engrafted with pOVA-specific CD8+ T cells.